Long noncoding RNA lincRNA-p21 is the major mediator of UVB-induced and p53-dependent apoptosis in keratinocytes

Cell Death and Disease

Volumn 6, Issue 3, 2015, Pages

  Hall, J R ^a   Messenger, Z J ^a   Tam, H W ^a   Phillips, S L ^b   Recio, L ^b   Smart, R C ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b ILS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA; PROTEIN P53;

ANIMAL; APOPTOSIS; BIOSYNTHESIS; CELL CYCLE CHECKPOINT; CELL LINE; CELL PROLIFERATION; DNA DAMAGE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KERATINOCYTE; METABOLISM; MOUSE; PATHOLOGY; RADIATION RESPONSE; SKIN; SKIN TUMOR; ULTRAVIOLET RADIATION;

ANIMALS; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE; CELL PROLIFERATION; DNA DAMAGE; GENE EXPRESSION REGULATION; HUMANS; KERATINOCYTES; MICE; RNA, LONG NONCODING; SKIN; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 84965084360     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/CDDIS.2015.67     Document Type: Article

References (51)

1. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J et al. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860–921.
2. Bertone P, Stolc V, Royce TE, Rozowsky JS, Urban AE, Zhu X et al. Global identification of human transcribed sequences with genome tiling arrays. Science 2004; 306: 2242–2246.
3. Kapranov P, Cheng J, Dike S, Nix DA, Duttagupta R, Willingham AT et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 2007; 316: 1484–1488.
4. Mattick JS. The genetic signatures of noncoding RNAs. PLoS Genet 2009; 5: e1000459.
5. Mercer TR, Gerhardt DJ, Dinger ME, Crawford J, Trapnell C, Jeddeloh JA et al. Targeted RNA sequencing reveals the deep complexity of the human transcriptome. Nat Biotechnol 2012; 30: 99–104.
6. Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A et al. Landscape of transcription in human cells. Nature 2012; 489: 101–108.
7. Hangauer MJ, Vaughn IW, McManus MT. Pervasive transcription of the human genome produces thousands of previously unidentified long intergenic noncoding RNAs. PLoS Genet 2013; 9: e1003569.
8. Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell 2009; 136: 629–641.
9. Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell 2011; 43: 904–914.
10. Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol 2012; 9: 703–719.
11. Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discov 2011; 1: 391–407.
12. Faghihi MA, Modarresi F, Khalil AM, Wood DE, Sahagan BG, Morgan TE et al. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med 2008; 14: 723–730.
13. Papait R, Kunderfranco P, Stirparo GG, Latronico MV, Condorelli G. Long noncoding RNA: a new player of heart failure? J Cardiovasc Transl Res 2013; 6: 876–883.
14. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009; 106: 9362–9367.
15. Sears ME, Genuis SJ. Environmental determinants of chronic disease and medical approaches: recognition, avoidance, supportive therapy, and detoxification. J Environ Public Health 2012; 2012: 356798.
16. Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 2010; 146: 283–287.
17. Kramata P, Lu YP, Lou YR, Singh RN, Kwon SM, Conney AH. Patches of mutant p53-immunoreactive epidermal cells induced by chronic UVB Irradiation harbor the same p53 mutations as squamous cell carcinomas in the skin of hairless SKH-1 mice. Cancer Res 2005; 65: 3577–3585.
18. Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P et al. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat 2007; 28: 622–629.
19. Tron VA, Trotter MJ, Tang L, Krajewska M, Reed JC, Ho VC et al. p53-regulated apoptosis is differentiation dependent in ultraviolet B-irradiated mouse keratinocytes. Am J Pathol 1998; 153: 579–585.
20. Wijnhoven SW, Speksnijder EN, Liu X, Zwart E, van Oostrom CT, Beems RB et al. Dominant-negative but not gain-of-function effects of a p53.R270H mutation in mouse epithelium tissue after DNA damage. Cancer Res 2007; 67: 4648–4656.
21. Wikonkal NM, Remenyik E, Knezevic D, Zhang W, Liu M, Zhao H et al. Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice. Nat Cell Biol 2003; 5: 655–660.
22. Ziegler A, Jonason AS, Leffell DJ, Simon JA, Sharma HW, Kimmelman J et al. Sunburn and p53 in the onset of skin cancer. Nature 1994; 372: 773–776.
23. Maeda T, Chong MT, Espino RA, Chua PP, Cao JQ, Chomey EG et al. Role of p21(Waf-1) in regulating the G1 and G2/M checkpoints in ultraviolet-irradiated keratinocytes. J Invest Dermatol 2002; 119: 513–521.
24. Jiang W, Ananthaswamy HN, Muller HK, Kripke ML. p53 protects against skin cancer induction by UV-B radiation. Oncogene 1999; 18: 4247–4253.
25. Li G, Ho VC, Berean K, Tron VA. Ultraviolet radiation induction of squamous cell carcinomas in p53 transgenic mice. Cancer Res 1995; 55: 2070–2074.
26. Li G, Tron V, Ho V. Induction of squamous cell carcinoma in p53-deficient mice after ultraviolet irradiation. J Invest Dermatol 1998; 110: 72–75.
27. van Kranen HJ, Westerman A, Berg RJ, Kram N, van Kreijl CF, Wester PW et al. Dose-dependent effects of UVB-induced skin carcinogenesis in hairless p53 knockout mice. Mutat Res 2005; 571: 81–90.
28. Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 2010; 142: 409–419.
29. Dimitrova N, Zamudio JR, Jong RM, Soukup D, Resnick R, Sarma K et al. LincRNA-p21 activates p21 in cis to promote polycomb target gene expression and to enforce the G1/S checkpoint. Mol Cell 2014; 54: 777–790.
30. Yoon JH, Abdelmohsen K, Srikantan S, Yang X, Martindale JL, De S et al. LincRNA-p21 suppresses target mRNA translation. Mol Cell 2012; 47: 648–655.
31. Recio L, Phillips SL, Maynor T, Waters M, Jackson AF, Yauk CL. Differential expression of long noncoding RNAs in the livers of female B6C3F1 mice exposed to the carcinogen furan. Toxicol Sci 2013; 135: 369–379.
32. Yang F, Zhang H, Mei Y, Wu M. Reciprocal regulation of HIF-1alpha and lincRNA-p21 modulates the Warburg effect. Mol Cell 2014; 53: 88–100.
33. Benavides F, Oberyszyn TM, VanBuskirk AM, Reeve VE, Kusewitt DF. The hairless mouse in skin research. J Dermatol Sci 2009; 53: 10–18.
34. Ramirez A, Page A, Gandarillas A, Zanet J, Pibre S, Vidal M et al. A keratin K5Cre transgenic line appropriate for tissue-specific or generalized Cre-mediated recombination. Genesis 2004; 39: 52–57.
35. Shim M, Powers KL, Ewing SJ, Zhu S, Smart RC. Diminished expression of C/EBPalpha in skin carcinomas is linked to oncogenic Ras and reexpression of C/EBPalpha in carcinoma cells inhibits proliferation. Cancer Res 2005; 65: 861–867.
36. Lehman TA, Modali R, Boukamp P, Stanek J, Bennett WP, Welsh JA et al. p53 mutations in human immortalized epithelial cell lines. Carcinogenesis 1993; 14: 833–839.
37. Aurelio ON, Kong XT, Gupta S, Stanbridge EJ. p53 mutants have selective dominant-negative effects on apoptosis but not growth arrest in human cancer cell lines. Mol Cell Biol 2000; 20: 770–778.
38. Olive KP, Tuveson DA, Ruhe ZC, Yin B, Willis NA, Bronson RT et al. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell 2004; 119: 847–860.
39. Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der Valk M, Berns A. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet 2001; 29: 418–425.
40. Brash DE. Sunlight and the onset of skin cancer. Trends Genet 1997; 13: 410–414.
41. Marin-Bejar O, Marchese FP, Athie A, Sanchez Y, Gonzalez J, Segura V et al. Pint lincRNA connects the p53 pathway with epigenetic silencing by the Polycomb repressive complex 2. Genome Biol 2013; 14: R104.
42. Hung T, Wang Y, Lin MF, Koegel AK, Kotake Y, Grant GD et al. Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet 2011; 43: 621–629.
43. DeOcesano-Pereira C, Amaral MS, Parreira KS, Ayupe AC, Jacysyn JF, Amarante-Mendes GP et al. Long non-coding RNA INXS is a critical mediator of BCL-XS induced apoptosis. Nucleic Acids Res 2014; 42: 8343–8355.
44. Zhou Y, Zhong Y, Wang Y, Zhang X, Batista DL, Gejman R et al. Activation of p53 by MEG3 non-coding RNA. J Biol Chem 2007; 282: 24731–24742.
45. Mourtada-Maarabouni M, Pickard MR, Hedge VL, Farzaneh F, Williams GT. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 2009; 28: 195–208.
46. Berg RJ, van Kranen HJ, Rebel HG, de Vries A, van Vloten WA, Van Kreijl CF et al. Early p53 alterations in mouse skin carcinogenesis by UVB radiation: immunohistochemical detection of mutant p53 protein in clusters of preneoplastic epidermal cells. Proc Natl Acad Sci USA 1996; 93: 274–278.
47. Jonason AS, Kunala S, Price GJ, Restifo RJ, Spinelli HM, Persing JA et al. Frequent clones of p53 keratinocytes in normal human skin. Proc Natl Acad Sci USA 1996; 93: 14025–14020.
48. Weissman BE, Aaronson SA. BALB and Kirsten murine sarcoma viruses alter growth and differentiation of EGF-dependent balb/c mouse epidermal keratinocyte lines. Cell 1983; 32: 599–606.
49. Yoon K, Smart RC. C/EBPalpha is a DNA damage-inducible p53-regulated mediator of the G1 checkpoint in keratinocytes. Mol Cell Biol 2004; 24: 10650–10660.
50. Thompson EA, Zhu S, Hall JR, House JS, Ranjan R, Burr JA et al. C/EBPalpha expression is downregulated in human nonmelanoma skin cancers and inactivation of C/EBPalpha confers susceptibility to UVB-induced skin squamous cell carcinomas. J Invest Dermatol 2011; 131: 1339–1346.
51. Ewing SJ, Zhu S, Zhu F, House JS, Smart RC. C/EBPbeta represses p53 to promote cell survival downstream of DNA damage independent of oncogenic Ras and p19(Arf). Cell Death Differ 2008; 15: 1734–1744.